Some case reports on Quinolones, a potent and globally popular group of antibiotics that are used to treat a wide range of infections, have raised concern about their possible association with acute hepatic failure (AHF). Data from the US FDA Adverse Event Reporting System were evaluated for signals of AHF in association with systemically administered quinolone antibiotics.
A recent study published by RSI’s Mohamed Taher, Franco Momoli, Donald Mattison and Daniel Krewski in the journal JGH Open: An open access journal of gastroenterology and hepatology, has shown that only ciprofloxacin displayed a marginal and significant AHF signal (PRR: 1.85 [1.21, 2.81]; EBGM: 1.54 [1.06, 1.81]); moxifloxacin, levofloxacin, and ofloxacin showed weak and nonsignificant signals.
The research team concluded that further pharmacovigilance studies are required to confirm the association between ciprofloxacin and AHF seen in the present analysis.
The paper is available by clicking here.
More RSI News
Risks of anticholinergic drugs
Adverse effects of drugs among the elderly should be given special attention when considering a pharmacological intervention. Two recent papers using large electronic health records…
Dr. Emma Hartnett Selected for JEMRA Roster of Scientific Experts
RSI’s Emma Hartnett has been selected to be part of the Joint FAO/WHO Expert Meetings on Microbiological Risk Assessment (JEMRA) Roster of Experts for a…
Safety Profiles of Newer Contraceptives presented at meeting of Society of Reproductive Investigation
RSI Chief Medical Officer, Dr. Donald R. Mattison, in collaboration with colleagues from the Institute for Safe Medication Practices and Wake Forest University, evaluated and…
Training Seminar in Systematic Review
RSI recently conducted an in-house training session in systematic review for its staff. The session featured a keynote presentation by Dr. Katya Tsaioun from Johns…